Marathon of Hope Cancer Centres Network publishes landmark paper in prestigious journal Cancer Cell

The Marathon of Hope Cancer Centres Network has reached a significant milestone today with the publication of its first landmark paper in a major scientific journal. Published in the prestigious journal Cancer Cell, the paper highlights the Network’s history, objectives and key accomplishments to date, underscoring how this unprecedented national collaboration is working to transform precision oncology in Canada.
It is authored by the entire Marathon of Hope Cancer Centres Network.
“The publication of this paper is a seminal moment for our Network, as it introduces us to the global scientific community and showcases how the Canadian cancer research community is working together like never before to improve outcomes and quality of life for cancer patients through precision medicine,” says Dr. André Veillette, Executive Director of the Network.
“Significantly, the paper also demonstrates the incredible scale of collaboration that defines our Network – it has more than 1,200 listed individual collaborators and recognizes over 100 funding and research partners – all of whom are uniting to bring real change to cancer research and care in this country.”
The paper was developed over the last year and a half, and was primarily written by Dr. Véronique LeBlanc, Network Program Manager and Scientific Writer, in close collaboration with Drs. Marco Marra (University of British Columbia) and Ian Watson (McGill University).
“We went through a meticulous process to put this together—from gathering insights from working group chairs to refining the draft with our Steering Committee and Network Council to getting approval from all our listed collaborators,” explains Dr. LeBlanc. “When it came to publication, we were thrilled when such a prestigious publication like Cancer Cell recognized the Network's leadership and expressed interest in the work. We were also delighted to be invited to publish in the journal's Special Review Issue on Bridging the Gap Between Foundational Cancer Biology and Clinical Oncology, a theme that brilliantly captures the Network's mission.”
The type of paper the Network just published is known as a marker paper. These papers aim to raise awareness within the scientific community about specific initiatives making an impact in a particular area of research. In this case, the paper focuses on the establishment of the Network, its vision and how it has brought together patients, researchers, clinicians, donors and administrators from across the country to develop a unified, pan-Canadian strategy for the advancement of precision oncology.
It also highlights the Network’s critical role in breaking down silos in Canada’s cancer research and care ecosystems, its commitment to equity and diversity in research and the central role that cancer patients, survivors and caregivers play in shaping all Network activities.
“Terry Fox’s vision was for all Canadians to be part of his Marathon of Hope,” says Dr. Watson. “As a Network, we’ve been working hard to embody that vision and create solutions that benefit everyone in Canada, no matter who they are or where they live. This paper is a way to celebrate this work and share meaningful successes and lessons learned, while also outlining the future direction of the Network.”
With the publication now available online in Cancer Cell, the Network hopes to inspire further collaboration within Canada and internationally to continue transforming the Canadian cancer research and care landscapes.
“This commentary is more than just a reflection of our progress,” says Dr. Marra. “It’s an invitation to the global research community to engage with our work, learn from our experiences, and help drive the next era of precision medicine.”
Watch now
Kirsten Efremov and Sarah Hunt, members of the Network's Patient Working Group, chat with Dr. Véronique LeBlanc, Network Program Manager and Scientific Writer, about the first landmark paper published by the Network in Cancer Cell (April 3, 2025)
Study
Authors
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network
"This paper introduces us to the global scientific community and showcases how the Canadian cancer research community is working together like never before to improve outcomes and quality of life for cancer patients through precision medicine."
Related Team Members
-
Ian
Institutional LeadMOHCCN Steering CommitteeWorking Group ChairWorking Group Member
Watson -
Marco
ResearcherMOHCCN Network CouncilWorking Group ChairConsortium LeaderWorking Group Member
Marra -
André
Executive Director
Veillette -
Véronique
Headquarters and Operations
LeBlanc
-
Regional Consortia
Atlantic Cancer Consortium
- Prince Edward Island
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more -
Regional Consortia
Pan-Canadian Projects
- Canada Wide
Building on work done by Regional Consortia across the country, the Pan-Canadian Projects program unites researchers and clinicians from multiple provinces to work on projects that accelerate precisio...Read more -
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more -
Regional Consortia
Marathon of Hope - Québec
- Québec
The Marathon of Hope – Québec (MOH-Q) brings together leading scientists and clinicians from hospitals and research centres including the Research Institute of the McGill University Health Centre (RI-...Read more -
Regional Consortia
Princess Margaret Cancer Consortium
- Ontario
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more -
Regional Consortia
Prairie Cancer Consortium
- Alberta
- Manitoba
- Saskatchewan
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more -
Regional Consortia
Atlantic Cancer Consortium
- Prince Edward Island
- New Brunswick
- Newfoundland and Labrador
- Nova Scotia
We have rallied our region’s leading cancer researchers, institutions and care facilities to unite around this vision to enhance inter-institutional and inter-provincial cancer research collaboration,...Read more -
Regional Consortia
Pan-Canadian Projects
- Canada Wide
Building on work done by Regional Consortia across the country, the Pan-Canadian Projects program unites researchers and clinicians from multiple provinces to work on projects that accelerate precisio...Read more -
Regional Consortia
BC Cancer Consortium
- British Columbia
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more -
Regional Consortia
Marathon of Hope - Québec
- Québec
The Marathon of Hope – Québec (MOH-Q) brings together leading scientists and clinicians from hospitals and research centres including the Research Institute of the McGill University Health Centre (RI-...Read more
Related News
-
Celebrating women in the Marathon of Hope Cancer Centres Network
In 1980, Terry Fox started a marathon against cancer. Forty-five years later, the Marathon of Hope Cancer Centres Network (MOHCCN) continues his vision, uniting the country to accelerate precision med... -
2025 kicks off with major milestones for our Network! A letter from Dr. André Veillette
Dr. André Veillette, Executive Director for Marathon of Hope Cancer Centres Network shares exciting updates from across the network -
Unifying Vision [EXTERNAL MEDIA]
Funding from the Government of Newfoundland and Labrador’s Department of Industry, Energy and Technology, totaling $1.19 million, is supporting Atlantic Cancer Consortium as a designated member of the... -
Dr. Marco Marra, Terry Fox Leader in Cancer Genome Science, appointed Officer of the Order of Canada
It is with heartfelt congratulations that we share that Dr. Marco Marra has been appointed an Officer of the Order of Canada (O.C.).